Capital & Focus Forward Ventures manages over $500 million in capital and maintains a focus on life sciences and health care venture investing across the United States with selective European opportunities, signaling potential for partnerships with early-stage to growth-stage biotech and med-tech startups.

Portfolio Growth Having invested in over 50 companies since 1993 and repeatedly funding new rounds like Forward V, there are multiple existing portfolio companies and alumni networks to engage for co-investment, strategic partnerships, or mutual deal flow opportunities.

Recent Wins Notable deals include Xanadu’s $200M raise with investors including major strategic and financial players, highlighting Forward Ventures’ ability to co-finance and attract significant capital, which can be leveraged to position new funding or syndication opportunities.

Market Positioning As a seasoned San Diego–based life sciences VC with broad national reach, there is potential to partner with academic spinouts, research institutions, and biotech startups seeking early-stage to late-stage funding, regulatory guidance, and strategic commercialization support.

Engagement Channels Existing tech stack signals a strong web and digital presence for outreach, while ongoing interest in cross-border opportunities suggests dedicated outreach to international biotech hubs and European opportunities could expand deal flow and co-investment prospects.